Genetics and Epigenetics in Neurodegenerative Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (15 September 2024) | Viewed by 1601
Special Issue Editor
Interests: genetics; geriatrics; dementia; cognitive decline; pharmacoepidemiology; pharmacogenetics; geriatrics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Research has shown that neurodegenerative diseases are largely influenced by genetic and epigenetic factors. Certain diseases such as Alzheimer’s disease, dementia, amyotrophic lateral sclerosis, Parkinson’s disease can appear randomly or be inherited. Finding predispositions, familial patterns, and particular gene changes associated with vulnerability all depend on genetic studies. Knowing these genetic variables helps to quantify risk and sheds light on the underlying processes that lead to the development and progression of disease.
In summary, the aim of this special issue entitled “Genetics and Epigenetics in Neurodegenerative Diseases” is to highlight the significance of genetic and genomic studies in neurodegenerative diseases and to show the current state and future directions for early detection and treatment, as well as to get a deeper comprehension of the complex necessities driving neurodegenerative diseases. Colleagues are encouraged to submit manuscripts with original articles or reviews in this topic.
Prof. Dr. Teresa Juárez-Cedillo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative disease
- genetics
- epigenetics
- Alzheimer’s disease
- dementia
- Parkinson’s disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
